title: Should serum IGF-I concentrations be monitored routinely during growth hormone therapy?
authors.affiliation: Great Ormond Street Hospital for Children and The Middlesex Hospital (UCLH), London, UK.
authors.forename: Maria
authors.initials: M
authors.lastname: Papagianni
authors.forename: Richard
authors.initials: R
authors.lastname: Stanhope
mesh_terms: D002648:Child; D013006:Growth Hormone / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D012307:Risk Factors
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone